Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
29 January 2026
Investor newsletter

INVESTOR NEWSLETTER – JANUARY 2026 (ENGLISH) Open in new window

29 January 2026
Investor newsletter

INVESTOR NEWSLETTER – JANUARY 2026 (FRENCH) Open in new window

28 January 2026
General Assembly, General meetings

Voting Result Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Shares and voting rights statement Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Rapport AK réservée aux salariés Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Notice and Convening Brochure Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Proxy voting form Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Preliminary Notice of the General Meeting Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Global delegation report Open in new window

29 December 2025
Financial statements and reports, Regulated information

ANNEX IX DECEMBER 2025 Open in new window

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 25
  • View next 9 articles
© 2026 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page